235 related articles for article (PubMed ID: 9552175)
1. Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands.
Couture S; Debonnel G
Synapse; 1998 May; 29(1):62-71. PubMed ID: 9552175
[TBL] [Abstract][Full Text] [Related]
2. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.
Monnet FP; Debonnel G; de Montigny C
J Pharmacol Exp Ther; 1992 Apr; 261(1):123-30. PubMed ID: 1532832
[TBL] [Abstract][Full Text] [Related]
3. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors.
Debonnel G; Bergeron R; de Montigny C
J Endocrinol; 1996 Sep; 150 Suppl():S33-42. PubMed ID: 8943785
[TBL] [Abstract][Full Text] [Related]
4. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
Bermack JE; Debonnel G
Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608
[TBL] [Abstract][Full Text] [Related]
5. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor.
Couture S; Debonnel G
Synapse; 2001 Mar; 39(4):323-31. PubMed ID: 11169783
[TBL] [Abstract][Full Text] [Related]
6. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
7. Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate.
Bergeron R; de Montigny C; Debonnel G
Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):252-60. PubMed ID: 7609778
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
Bergeron R; de Montigny C; Debonnel G
Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
[TBL] [Abstract][Full Text] [Related]
9. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.
Bergeron R; Debonnel G
Psychopharmacology (Berl); 1997 Feb; 129(3):215-24. PubMed ID: 9084059
[TBL] [Abstract][Full Text] [Related]
10. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
[TBL] [Abstract][Full Text] [Related]
11. The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.
Monnet FP; Debonnel G; de Montigny C
Synapse; 1993 Jan; 13(1):30-8. PubMed ID: 8427011
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.
Bergeron R; de Montigny C; Debonnel G
J Neurosci; 1996 Feb; 16(3):1193-202. PubMed ID: 8558248
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
15. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
Monnet FP; Debonnel G; Bergeron R; Gronier B; de Montigny C
Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892
[TBL] [Abstract][Full Text] [Related]
16. Steroids modulate N-methyl-D-aspartate-stimulated [3H] dopamine release from rat striatum via sigma receptors.
Nuwayhid SJ; Werling LL
J Pharmacol Exp Ther; 2003 Sep; 306(3):934-40. PubMed ID: 12750428
[TBL] [Abstract][Full Text] [Related]
17. N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.
Berardi F; Santoro S; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1998 Oct; 41(21):3940-7. PubMed ID: 9767631
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hyperpolarization-activated cation currents by phencyclidine and some sigma ligands in rat hippocampal CA1 pyramidal neurons in vitro.
Tanabe M
Neuropharmacology; 2007 Sep; 53(3):406-14. PubMed ID: 17631922
[TBL] [Abstract][Full Text] [Related]
20. Novel sigma receptor ligands: synthesis and biological profile.
Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
